We are live on ! Find out more
BLFS icon

BioLife Solutions
BLFS

75 hedge funds and large institutions have $116M invested in BioLife Solutions in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 27 increasing their positions, 25 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

8.97% more ownership

Funds ownership: 50.04% → 59.01% (+9%)

8% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 25

6% less funds holding

Funds holding: 80 → 75 (-5)

19% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 16

30% less capital invested

Capital invested by funds: $168M → $116M (-$51.1M)

96% less call options, than puts

Call options by funds: $7K | Put options by funds: $191K

Holders
75
Holders Change
-5
Holders Change %
-6.25%
% of All Funds
1.65%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.07%
New
13
Increased
27
Reduced
25
Closed
16
Calls
$7K
Puts
$191K
Net Calls
-$184K
Net Calls Change
+$74K

Top Buyers

Rank Fund Capital Flow
1
SPA
Sentinel Pension Advisors
Massachusetts
+$15.1M
2
TC
Tarsadia Capital
New York
+$6.56M
3
PCM
Penn Capital Management
Pennsylvania
+$4.43M
4
RA
Royce & Associates
New York
+$3.57M
5
BL
Bleichroeder LP
New York
+$2.91M

Top Sellers

Rank Fund Capital Flow
1
DCM
Driehaus Capital Management
Illinois
-$7.71M
2
GC
GMT Capital
Georgia
-$4.11M
3
PHP
Parkman Healthcare Partners
Connecticut
-$2.69M
4
SCM
Sandler Capital Management
New York
-$2.07M
5
Russell Investments Group
Russell Investments Group
United Kingdom
-$1.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
76
Driehaus Capital Management
Illinois
– -$7.71M -476,285 Closed
GC
77
GMT Capital
Georgia
– -$4.11M -254,007 Closed
PHP
78
Parkman Healthcare Partners
Connecticut
– -$2.69M -166,000 Closed
CCM
79
Cadence Capital Management
Massachusetts
– -$982K -60,688 Closed
Goldman Sachs
80
Goldman Sachs
New York
– -$702K -43,402 Closed
T. Rowe Price Associates
81
T. Rowe Price Associates
Maryland
– -$485K -29,957 Closed
MFG
82
Magnus Financial Group
New York
– -$451K -27,848 Closed
SKK
83
Shepherd Kaplan Krochuk
Massachusetts
– -$227K -14,000 Closed
JG
84
Jefferies Group
New York
– -$211K -13,065 Closed
SSA
85
Schonfeld Strategic Advisors
New York
– -$184K -11,400 Closed
CIP
86
Cornerstone Investment Partners
Georgia
– -$168K -10,365 Closed
MWNA
87
Marshall Wace North America
New York
– -$64K -3,935 Closed
VCP
88
Verus Capital Partners
Arizona
– -$32K -2,000 Closed
OAM
89
Oppenheimer Asset Management
New York
– -$19K -1,189 Closed
AIM
90
Aigen Investment Management
New York
– -$16K -986 Closed
SF
91
Synovus Financial
Georgia
– -$1K -60 Closed
1 2 3
4

BLFS Hedge Fund Activity: Q1 2020 in Review

75 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q1 2020, worth a combined $116M — down 30% from $168M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of BLFS and 13 opened new positions — a net loss of 3 holders — while 25 trimmed existing stakes and 27 added.

The largest buyer was Sentinel Pension Advisors, opening a new position worth an estimated $15.1M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $7.71M sold.

  • 75 institutional investors held BioLife Solutions (BLFS) as of Q1 2020, down from 80 in Q4 2019.
  • Funds reported $116M of BioLife Solutions stock for Q1 2020, down 30% quarter-over-quarter.
  • 13 funds opened new BioLife Solutions positions in Q1 2020 and 16 closed out, a net change of -3 holders.
  • The largest BioLife Solutions buyer in Q1 2020 was Sentinel Pension Advisors, an estimated $15.1M added.
  • The largest BioLife Solutions seller in Q1 2020 was Driehaus Capital Management, an estimated $7.71M sold.

Based on aggregated 13F filings for Q1 2020.